Can a patient still have cervical myelopathy when MRI shows multilevel spinal cord compression with severe canal stenosis and foraminal stenosis but no myelomalacia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cervical Myelopathy Without Myelomalacia

Yes, a patient can absolutely have cervical myelopathy with multilevel cord compression and severe stenosis even without myelomalacia on MRI. Myelomalacia is a prognostic indicator, not a diagnostic requirement for myelopathy.

Clinical Diagnosis Takes Precedence

Myelopathy is fundamentally a clinical diagnosis based on physical examination findings localized to the spinal cord, not purely an imaging diagnosis 1. The presence of radiographic cord compression without myelomalacia does not exclude myelopathy if clinical signs are present.

Key Clinical Findings to Assess

Look specifically for these long-tract signs on examination 2:

  • Upper motor neuron signs: Hoffman sign, Babinski sign, hyperreflexia, clonus, crossed abductor sign
  • Gait dysfunction: Wide-based, unsteady gait
  • Hand clumsiness: Decreased fine motor dexterity
  • Sensory deficits: Dermatomal or nondermatomal patterns
  • Bowel/bladder dysfunction: In advanced cases 3

Radiographic Correlation

Cord Compression Without Signal Change

Research demonstrates that 62% of patients with clinical myelopathy have cord compression on MRI, and 84% of those with cord compression have myelopathic findings on examination 2. Critically, no patients without cord compression presented with myelopathy in this cohort, establishing cord compression as highly correlative but not requiring signal changes 2.

Myelomalacia as a Prognostic Factor

Intramedullary T2 hyperintensity (myelomalacia) represents a prognostic factor for surgical outcomes, not a diagnostic criterion 1. Only 35% of patients with clinical myelopathy demonstrate T2 hyperintensity within the spinal cord parenchyma 2. The ACR guidelines explicitly state that while MRI best discerns myelomalacia and gliosis, these imaging changes are prognostic indicators rather than diagnostic requirements 1.

Paradoxical Timing of Signal Changes

Evidence shows that absence of T2 hyperintensity may predict early myelopathy development (<12 months), while presence predicts late development (mean 44 months) 4. This counterintuitive finding suggests that signal changes evolve over time and their absence does not exclude active myelopathy.

Natural History Without Signal Changes

For patients with cervical stenosis and cord compression without myelomalacia 4:

  • 8% develop clinical myelopathy at 1-year follow-up
  • 23% develop myelopathy at median 44-month follow-up
  • Symptomatic radiculopathy, prolonged evoked potentials, and clinical radicular dysfunction increase risk of progression

Clinical Decision-Making Algorithm

If your patient has:

  1. Multilevel cord compression + severe stenosis on MRI (confirmed)
  2. ≥2 long-tract signs on examination (Hoffman, Babinski, hyperreflexia, clonus, gait dysfunction) 2
  3. No alternative neurologic explanation

Then diagnose cervical myelopathy regardless of myelomalacia presence 1, 2.

Surgical Referral Indications

Prompt referral to spine surgery is recommended for any patient with suspected myelopathy, as delayed diagnosis leads to long-term disability 5. Patients with moderate-to-severe disease require operative treatment 5.

Patients with cord compression, clinical/electrophysiological radicular dysfunction, or central conduction deficits are at higher risk for progression and should be counseled to consider surgical treatment 4.

Common Pitfalls to Avoid

  • Do not wait for myelomalacia to appear before diagnosing myelopathy - it may develop late or not at all 2, 4
  • Do not dismiss clinical findings because imaging lacks signal changes - 65% of myelopathy patients lack T2 hyperintensity 2
  • Do not assume neurologic level matches stenosis level - EMG studies show LMN involvement is typically 1-4 levels below the stenotic canal 6
  • Do not overlook lower extremity-only presentations - cervical myelopathy can present without upper extremity signs 3
  • Do not rely solely on ICD-10 coding - 18-22% of patients coded for radiculopathy have concurrent myelopathy 7

Related Questions

In a patient with cervical foraminal stenosis and a congenitally narrow central canal causing fine‑motor impairment, unilateral hand‑dropping, radicular pain, arm and leg weakness, and hip/hamstring tightness, could the thumb shaking seen during precise movements on a video‑game controller be a manifestation of cervical myelopathy rather than a primary tremor disorder?
Given ventral spinal cord flattening at C5‑6 on MRI with normal cord signal, hyperreflexia, brisk reflexes, and prior urinary hesitancy that has improved, should I be concerned about cervical myelopathy?
In an 86‑year‑old woman with several days of right‑sided head and facial paresthesias, right neck and arm pain, a normal brain MRI, and cervical MRI showing multilevel spondylosis with severe central canal stenosis and cord compression at C4‑5 (moderate cord deformity at C5‑6), what laboratory studies and additional diagnostic tests should be obtained?
Can cervical spinal stenosis with radiculopathy and myelopathy cause hip tightness?
Can cervical myelopathy cause bilateral hamstring muscle hypertonicity?
Does taking venlafaxine 150 mg daily together with lisdexamfetamine (Vyvanse) 30 mg increase fatigue?
What deep breathing exercises (diaphragmatic breathing) should be performed, including technique, frequency, duration, and contraindications?
Does diaphragmatic breathing provide benefit for cough?
What are the differences between rosuvastatin and pravastatin in terms of potency, metabolism, dosing, and safety profile?
Is low blood glucose sensation in a patient taking dapagliflozin (Farxiga) indicative of hypoglycemia, and how should it be evaluated and managed?
What is the maximum dose of Entresto (sacubitril/valsartan) for an adult patient with chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.